Lifestyle Modifications : We emphasize the importance of a healthy lifestyle alongside treatment
The full scope at Ascend includes: Obesity and overweight with comorbidities - full workup, GLP-1 candidacy assessment, lifestyle integration Type 2 diabetes with weight management goals - GLP-1 medications often address both indications simultaneously Hypertension tied to weight - coordinated medication review and lifestyle work Dyslipidemia and metabolic syndrome - lipids often improve markedly with weight loss Prediabetes - HbA1c 5.7-6.4% range, where intervention can prevent progression Fatty liver disease (MASLD) - weight loss is the primary intervention
Some studies have reported positive results for these diseases, exploring the potential for healthcare professionals
Caused by blocked airways, apnea often causes problems in people with obesity because it is thought to increase the volume of tissue pressing down on their windpipe during sleep
Packaging Quality & Security Minor issues Heres where things got sloppy
For example, a 2023 study showed that in the next 3 hours after consuming carbs, there was a 65% increase in GLP-1 , which is considerably more than in the placebo group**
